News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
104,978 Results
Type
Article (7481)
Company Profile (39)
Press Release (97453)
Multimedia
Podcasts (25)
Webinars (5)
Section
Business (29248)
Career Advice (150)
Deals (4269)
Drug Delivery (50)
Drug Development (14717)
Employer Resources (12)
FDA (3168)
Job Trends (2186)
News (51958)
Policy (6359)
Tag
2027 Biotech Bay Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (454)
Accelerated approval (25)
ADA (4)
Adcomms (11)
Allergies (67)
Alliances (9270)
ALS (56)
Alzheimer's disease (423)
Antibody-drug conjugate (ADC) (206)
Approvals (3142)
Artificial intelligence (222)
ASCO (73)
Autoimmune disease (147)
Automation (18)
Bankruptcy (21)
Best Places to Work (1822)
BIO (20)
BIOSECURE Act (17)
Biosimilars (187)
Biotechnology (28)
Bladder cancer (62)
Brain cancer (21)
Breast cancer (172)
Cancer (1422)
Cardiovascular disease (77)
Career advice (136)
Career pathing (8)
CAR-T (70)
CDC (13)
Cell therapy (254)
Cervical cancer (14)
Clinical research (13380)
Collaboration (656)
Company closure (3)
Compensation (131)
Complete response letters (56)
COVID-19 (634)
CRISPR (19)
C-suite (278)
Cystic fibrosis (18)
Data (2197)
Denatured (6)
Depression (21)
Dermatology (38)
Diabetes (110)
Diagnostics (669)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (146)
Drug pricing (42)
Drug shortages (2)
Duchenne muscular dystrophy (104)
Earnings (11377)
Editorial (24)
Employer branding (3)
Employer resources (11)
Events (13831)
Executive appointments (239)
FDA (4295)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (11)
Funding (413)
Gene editing (61)
Generative AI (32)
Gene therapy (253)
GLP-1 (187)
Government (1458)
Grass and pollen (1)
Guidances (94)
Healthcare (2053)
Hematology (52)
HIV (19)
Huntington's disease (21)
IgA nephropathy (29)
Immunology and inflammation (113)
Immuno-oncology (46)
Indications (53)
Infectious disease (747)
Inflammatory bowel disease (94)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (55)
Interviews (13)
IPO (2021)
IRA (16)
Job creations (402)
Job search strategy (124)
JPM (9)
Kidney cancer (7)
Labor market (12)
Layoffs (76)
Leadership (4)
Legal (577)
Liver cancer (14)
Longevity (21)
Lung cancer (209)
Lymphoma (99)
Machine learning (24)
Management (2)
Manufacturing (487)
Marketing (2)
MASH (38)
Medical device (1212)
Medtech (1241)
Mergers & acquisitions (2478)
Metabolic disorders (261)
mRNA (55)
Multiple sclerosis (57)
NASH (2)
Neurodegenerative disease (129)
Neuropsychiatric disorders (10)
Neuroscience (793)
NextGen: Class of 2026 (717)
Non-profit (378)
Now hiring (29)
Obesity (97)
Opinion (84)
Ovarian cancer (54)
Pain (40)
Pancreatic cancer (54)
Parkinson's disease (87)
Partnered (10)
Patents (120)
Patient recruitment (151)
Peanut (31)
People (9103)
Pharmaceutical (10)
Pharmacy benefit managers (7)
Phase 1 (4373)
Phase 2 (5601)
Phase 3 (4893)
Pipeline (2791)
Policy (143)
Postmarket research (301)
Preclinical (1744)
Press Release (66)
Prostate cancer (59)
Psychedelics (10)
Radiopharmaceuticals (56)
Rare diseases (313)
Real estate (977)
Recruiting (5)
Regulatory (6193)
Reports (13)
Research institute (421)
Resumes & cover letters (16)
Rett syndrome (14)
RNA editing (6)
RSV (23)
Schizophrenia (34)
Series A (86)
Series B (50)
Service/supplier (3)
Sickle cell disease (26)
Special edition (6)
Spinal muscular atrophy (27)
Sponsored (20)
Startups (615)
State (1)
Stomach cancer (5)
Supply chain (28)
Tariffs (21)
The Weekly (19)
Vaccines (371)
Venture capital (20)
Weight loss (47)
Women's health (15)
Date
Today (33)
Last 7 days (143)
Last 30 days (596)
Last 365 days (6976)
2026 (3902)
2025 (6451)
2024 (6870)
2023 (7491)
2022 (9482)
2021 (9906)
2020 (8516)
2019 (6046)
2018 (4657)
2017 (5231)
2016 (4718)
2015 (5424)
2014 (3814)
2013 (2968)
2012 (3068)
2011 (3222)
2010 (2655)
Location
Africa (102)
Alabama (19)
Alaska (1)
Arizona (30)
Arkansas (3)
Asia (8715)
Australia (1006)
California (2977)
Canada (605)
China (571)
Colorado (63)
Connecticut (140)
Delaware (131)
Europe (15632)
Florida (418)
Georgia (57)
Hawaii (1)
Idaho (14)
Illinois (137)
India (50)
Indiana (80)
Iowa (11)
Japan (151)
Kansas (12)
Kentucky (16)
Louisiana (4)
Maine (26)
Maryland (538)
Massachusetts (2238)
Michigan (39)
Minnesota (97)
Mississippi (4)
Missouri (32)
Montana (5)
Nebraska (1)
Nevada (20)
New Hampshire (6)
New Jersey (939)
New Mexico (4)
New York (851)
North Carolina (385)
North Dakota (10)
Northern California (1521)
Ohio (84)
Oklahoma (13)
Oregon (6)
Pennsylvania (484)
Puerto Rico (6)
Rhode Island (8)
South America (144)
South Carolina (4)
Southern California (1221)
Tennessee (17)
Texas (455)
United States (10276)
Utah (56)
Virginia (39)
Washington D.C. (10)
Washington State (221)
West Virginia (1)
Wisconsin (20)
104,978 Results for "cmc biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development
March 10, 2026
·
2 min read
Press Releases
USP Publishes Product-Specific Emerging Biologics Standards for Public Comment
Advancing efficiency and alignment in biologics development, through product-specific methods, to support broader availability of biologics, including biosimilars, for patients
June 1, 2026
·
4 min read
Press Releases
Forlong Biotechnology Announced CMC Readiness to Initiate GMP Batch Production to Support Upcoming Pivotal Clinical Trial for FL115 (IL-15 Superagonist) in Nonmuscle Invasive Bladder Cancer (NMIBC)
April 15, 2026
·
4 min read
Press Releases
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
May 14, 2026
·
11 min read
Press Releases
Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies
April 23, 2025
·
2 min read
Press Releases
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
June 8, 2026
·
4 min read
Press Releases
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
November 20, 2025
·
7 min read
Press Releases
Applied Biologics Announces National Commercial Expansion to Support Continued Growth of XWRAP® and Future Biologic Product Pipeline
June 30, 2026
·
3 min read
Press Releases
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
May 22, 2026
·
3 min read
Press Releases
INTENT Biologics Receives FDA Breakthrough Therapy Designation for PEP Biologic™ for its Phase 3 Ready Flagship Indication
July 1, 2026
·
4 min read
1 of 10,498
Next
